Third set of awards are announced under interagency biodiversity program

to identify new drugs through screening of flora and fauna while protecting biodiversity. The groups are consortia of public and private institutions, including universities, pharmaceutical companies, government agencies and indigenous environmental and community groups.

Projects include the identification and characterization of chemical compounds derived from biological diversity that have potential as therapeutic agents for diseases such as cancer, AIDS, parasitic diseases, drug addiction, mental conditions and heart disease, all of which are of concern to both developed and developing countries. Other important components include evaluation of traditional medicine practices, discovery of safe new agents for agricultural applications, conduct of biodiversity surveys and Inventories, development of strategies to ensure sustainable yield of biodiversity-based therapies, and training and infrastructure support for host-country scientific institutions.

Intellectual property agreements are negotiated among participating institutions so that economic and other benefits from both the research process and products are equitably shared and accrue to local institutions and communities involved. Contributions from pharmaceutical and agroscience companies include screening for therapeutic potential, training opportunities, technology donations, financial support, and royalties from the sale of any product developed as a result of ICBG research.


ICBG awards include five comprehensive projects and seven planning grants. Comprehensive projects include the following:

  • William Gerwick in collaboration with Phyllis D. Coley and colleagues at the Smithsonian Tropical Research Institute, building on a previous five-year ICBG award, are using ecological insight to build a sustainable bioprospecting program in Panama for discovery of both pharmaceutical and agricultural products from plants and marine

Contact: Cheryl Dybas
National Science Foundation

Page: 1 2 3 4 5

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Large brains not required? Third and smallest skull of first Eurasians reported in Science
3. Rutgers scientists create high-protein corn with Third World potential
4. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
5. Third Wave scientists publish advance in gene expression monitoring with revolutionary RNA Invader Assay
6. University Of Kentucky Researcher Awarded MERIT Extension For Study Of Third World Killer
7. Third Annual Awards For Presidential Green Chemistry Challenge Recognize Innovations
8. Fortified Drink Improves Third World Nutrition
9. Chemical engineering grad students will take notable national awards
10. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
11. NSF awards 22 new projects for plant genome research

Post Your Comments:

(Date:1/27/2020)... ... , ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), join ... Richard Castle, Global Account Manager Medical Device at PRISYM ID for an ... timing deadlines, best practices in creating and submitting product data and best practices in ...
(Date:1/23/2020)... ATLANTA (PRWEB) , ... January 23, 2020 , ... ... to manufacture lifesaving mature red blood cells from stem cells. The red ... red blood cells, under strictly controlled conditions, for transfusion therapy and replaces the ...
(Date:1/22/2020)... ... January 21, 2020 , ... Modality ... supporting global regulatory applications, and executing global clinical trial operations. Milestone highlights ... a fastest growing company, and ISO 9001:2015 certification with the scope of ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... ... February 03, 2020 , ... Ovation Travel Group ... Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All of the ... following statistics:, Average airfare price paid Domestically, Internationally ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in ... computing, today announced the availability of neuroscience of transformational leadership workshops. These highly ... neuroscience of leadership and change research to become great transformational leaders. The ...
(Date:1/23/2020)... ... 2020 , ... Ideal Implant CEO and President Robert S ... North American investor forums specializing in medical advancements. New technology was presented to ... on November 21, 2019 in New York City, and the Aesthetic Technology Summit ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
Breaking Biology Technology:
Cached News: